HP
HealthInvest Partners Portfolio holdings
AUM
$234M
This Quarter Return
-5.06%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-19%)
Cap. Flow
-$19.7M
Cap. Flow
% of AUM
-18.15%
Top 10 Holdings %
Top 10 Hldgs %
81.1%
Holding
19
New
4
Increased
1
Reduced
9
Closed
4
Top Buys
| 1 |
Gilead Sciences
GILD
|
$8.09M |
| 2 |
McKesson
MCK
|
$8.01M |
| 3 |
ELOS
Syneron Medical Ltd
ELOS
|
$5.93M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$4.01M |
| 5 |
Alphatec Holdings
ATEC
|
$1.37M |
Top Sells
| 1 |
Elevance Health
ELV
|
$11.4M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$9.94M |
| 3 |
Cencora
COR
|
$8.21M |
| 4 |
Cardinal Health
CAH
|
$8.13M |
| 5 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$1.77M |
Sector Composition
| 1 | Healthcare | 83.29% |
| 2 | Financials | 6.95% |
| 3 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Supernus Pharmaceuticals
SUPN
$2.53B
| $13.6M | 12.52% | 538,241 +158,708 | +42% | +$4.01M |
|
2
Anika Therapeutics
ANIK
$135M
| $8.62M | 7.94% | 175,967 -27,526 | -14% | -$1.35M |
|
|
3
Cardinal Health
CAH
$35.5B
| $8.48M | 7.81% | 117,800 -113,000 | -49% | -$8.13M |
|
4
Charles River Laboratories
CRL
$8.04B
| $8.47M | 7.8% | 111,112 -7,500 | -6% | -$571K |
|
|
5
Cencora
COR
$56.5B
| $8.37M | 7.71% | 107,000 -105,000 | -50% | -$8.21M |
|
|
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $8.31M | 7.65% | 78,905 -6,300 | -7% | -$663K |
|
|
7
Elevance Health
ELV
$71.8B
| $8.09M | 7.46% | 56,300 -79,600 | -59% | -$11.4M |
|
|
8
Gilead Sciences
GILD
$140B
| $8.09M | 7.46% | +113,000 | New | +$8.09M |
|
9
Merck
MRK
$210B
| $8.01M | 7.38% | 136,100 -21,000 | -13% | -$1.24M |
|
|
10
McKesson
MCK
$85.4B
| $8.01M | 7.38% | +57,000 | New | +$8.01M |
|
|
GTS
11
DELISTED
Triple-S Management Corporation
GTS
| $7.54M | 6.95% | 364,156 -65,748 | -15% | -$1.36M |
|
|
ELOS
12
DELISTED
Syneron Medical Ltd
ELOS
| $5.93M | 5.46% | +706,107 | New | +$5.93M |
|
|
GNC
13
DELISTED
GNC Holdings, Inc.
GNC
| $4.67M | 4.3% | 422,955 -60,000 | -12% | -$662K |
|
|
14
Alphatec Holdings
ATEC
$2.35B
| $1.37M | 1.26% | +426,855 | New | +$1.37M |
|
15
ImmuCell
ICCC
$57.9M
| $1M | 0.92% | 168,323 | – | – |
|
16
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42.1B
| – | – | -20,000 | Closed | -$915K |
|
17
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| – | – | -10,000 | Closed | -$850K |
|
|
SYNH
18
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – | -222,875 | Closed | -$9.94M |
|
|
PGNX
19
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| – | – | -280,000 | Closed | -$1.77M |
|